To access this element change to forms mode OFF
Grant Award View - GA30261
Transforming the treatment landscape in elderly Acute Myeloid Leukaemia
GA ID:
GA30261
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$1,071,166.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Transforming the treatment landscape in elderly Acute Myeloid Leukaemia
Purpose:
The majority of patients with AML are elderly and unfit for intensive chemotherapy. Standard low-intensity therapy is generally unsuccessful and survival short-lived. We have recently led ground-breaking studies showing that targeting the cell-survival machinery with the BCL-2 inhibitor venetoclax in combination with chemotherapy is an exciting therapeutic prospect. We have now identified two non-overlapping mechanisms of resistance to this regimen amendable to combination with novel inhibitors.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162809
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, NEW ZEALAND, UNITED STATES